DrugDev More than Doubles New Business Orders in 2017 as Global Pharma Industry Accelerates Enterprise Implementation of the DrugDev Spark™ Clinical Operations Suite
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: PR Web
PHILADELPHIA and LONDON (PRWEB) February 05, 2018 DrugDev achieved tremendous growth in 2017 as pharma and biotech organizations of all sizes worldwide adopted its strategy to advance clinical trials through industry-wide collaboration, standardization and a beautiful technology experience. The company more than doubled new business orders as adoption of the DrugDev Spark™ clinical operations suite continues to steadily climb to over 100 pharmaceutical and biotechnology customers. On top of this success, several of the world's leading global drug development companies committed to improving the site, patient and study team experience for their clinical trials by implementing DrugDev Spark enterprise wide across thousands of global trials. The organic growth and enterprise success together resulted in the staggering growth over what was a prosperous 2016.DrugDev President and CEO Ibs Mahmood said, "Even someone as optimistic as I am could not have predicted the global impact DrugDev w
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Strategies for Biomarker-Driven Sub-population Optimization in Clinical Trials, Upcoming Webinar Hosted by XtalksPR Web
- Reasons to Retain IQVIA (IQV) Stock in Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly [Yahoo! Finance]Yahoo! Finance
- IQVIA to Announce First-Quarter 2024 Results on May 2, 2024Business Wire
- Global In Vivo CRO Market Analysis Report 2024-2030, Featuring IQVIA, Crown Bioscience, Taconic Biosciences, PsychoGenics, Evotec, Janvier Labs, Biocytogen Boston, GemPharmatech and Parexel [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 2/14/24 - Beat
IQV
Sec Filings
- 4/17/24 - Form 8-K
- 3/4/24 - Form 4
- 3/4/24 - Form 4
- IQV's page on the SEC website